Search

Brenda Libby Coleman

Examiner (ID: 13884, Phone: (571)272-0665 , Office: P/1624 )

Most Active Art Unit
1624
Art Unit(s)
1202, 2611, 1624, 1611
Total Applications
3154
Issued Applications
1967
Pending Applications
488
Abandoned Applications
741

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14359951 [patent_doc_number] => 10301262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders [patent_app_type] => utility [patent_app_number] => 15/738175 [patent_app_country] => US [patent_app_date] => 2016-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 43779 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738175 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/738175
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders Jun 20, 2016 Issued
Array ( [id] => 13944491 [patent_doc_number] => 10208001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry [patent_app_type] => utility [patent_app_number] => 15/565589 [patent_app_country] => US [patent_app_date] => 2016-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2868 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565589 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/565589
Process for preparing 1,4-dibenzodiazepines via Buchwald-Hartwig chemistry Jun 20, 2016 Issued
Array ( [id] => 14794015 [patent_doc_number] => 10400000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 15/735372 [patent_app_country] => US [patent_app_date] => 2016-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 16040 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15735372 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/735372
Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof Jun 12, 2016 Issued
Array ( [id] => 16276725 [patent_doc_number] => 10759739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-01 [patent_title] => P62-ZZ small molecule modulators [patent_app_type] => utility [patent_app_number] => 15/580643 [patent_app_country] => US [patent_app_date] => 2016-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10027 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580643 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/580643
P62-ZZ small molecule modulators Jun 6, 2016 Issued
Array ( [id] => 14171575 [patent_doc_number] => 10259782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => ROR gamma (RORg) modulators [patent_app_type] => utility [patent_app_number] => 15/579143 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6361 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 479 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579143 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/579143
ROR gamma (RORg) modulators Jun 2, 2016 Issued
Array ( [id] => 15008421 [patent_doc_number] => 10450326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => Thiazolopyrimidinone compounds and preparation methods and use thereof [patent_app_type] => utility [patent_app_number] => 15/577725 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10687 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577725 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/577725
Thiazolopyrimidinone compounds and preparation methods and use thereof Jun 2, 2016 Issued
Array ( [id] => 14611527 [patent_doc_number] => 10358449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-23 [patent_title] => Xanthine derivative [patent_app_type] => utility [patent_app_number] => 15/577946 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5134 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577946 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/577946
Xanthine derivative May 25, 2016 Issued
Array ( [id] => 11901908 [patent_doc_number] => 09771332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => '2-thiopyrimidinones' [patent_app_type] => utility [patent_app_number] => 15/144234 [patent_app_country] => US [patent_app_date] => 2016-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14349 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144234 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/144234
2-thiopyrimidinones May 1, 2016 Issued
Array ( [id] => 15466087 [patent_doc_number] => 10548897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-04 [patent_title] => KSR antagonists [patent_app_type] => utility [patent_app_number] => 15/566565 [patent_app_country] => US [patent_app_date] => 2016-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 23519 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566565 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/566565
KSR antagonists Apr 14, 2016 Issued
Array ( [id] => 14485059 [patent_doc_number] => 10329296 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Indole derivatives [patent_app_type] => utility [patent_app_number] => 15/563259 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16112 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563259 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/563259
Indole derivatives Apr 13, 2016 Issued
Array ( [id] => 12837238 [patent_doc_number] => 20180170919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => CRYSTALINE FORMS OF N-[6-(CIS-2,6-DIMETHYLMORPHOLINE -4-YL)PYRIDINE-3-YL]-2-METHYL-4'-(TRIFLUOROMETHOXY) [1,1'-BIPHENYL]-3-METHANAMIDE MONOPHOSPHATE, AND PROCESS OF PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 15/579881 [patent_app_country] => US [patent_app_date] => 2016-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579881 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/579881
Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4'-(trifluoromethoxy) [1,1'-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof Mar 29, 2016 Issued
Array ( [id] => 11083736 [patent_doc_number] => 20160280701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'INHIBITORS OF COLLAGEN PROLYL 4-HYDROXYLASE' [patent_app_type] => utility [patent_app_number] => 15/082372 [patent_app_country] => US [patent_app_date] => 2016-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 31397 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082372 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/082372
Inhibitors of collagen prolyl 4-hydroxylase Mar 27, 2016 Issued
Array ( [id] => 12680653 [patent_doc_number] => 20180118717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => Substituted Quinazoline Derivatives as DNA Methyltransferase Inhibitors [patent_app_type] => utility [patent_app_number] => 15/560883 [patent_app_country] => US [patent_app_date] => 2016-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560883 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560883
Substituted quinazoline derivatives as DNA methyltransferase inhibitors Mar 24, 2016 Issued
Array ( [id] => 13942343 [patent_doc_number] => 10206916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Cabozantinib salts and their use as anti-cancer agents [patent_app_type] => utility [patent_app_number] => 15/560519 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8779 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560519 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560519
Cabozantinib salts and their use as anti-cancer agents Mar 21, 2016 Issued
Array ( [id] => 11003771 [patent_doc_number] => 20160200721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'AROMATIC HETEROCYCLYLAMINE DERIVATIVE HAVING TRPV4-INHIBITING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/076728 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24628 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076728 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/076728
Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity Mar 21, 2016 Issued
Array ( [id] => 11003771 [patent_doc_number] => 20160200721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'AROMATIC HETEROCYCLYLAMINE DERIVATIVE HAVING TRPV4-INHIBITING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/076728 [patent_app_country] => US [patent_app_date] => 2016-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24628 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15076728 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/076728
Aromatic heterocyclylamine derivative having TRPV4-inhibiting activity Mar 21, 2016 Issued
Array ( [id] => 11107518 [patent_doc_number] => 20160304489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide' [patent_app_type] => utility [patent_app_number] => 15/073766 [patent_app_country] => US [patent_app_date] => 2016-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18548 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15073766 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/073766
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide Mar 17, 2016 Issued
Array ( [id] => 14171641 [patent_doc_number] => 10259815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Gabaergic ligands and their uses [patent_app_type] => utility [patent_app_number] => 15/560002 [patent_app_country] => US [patent_app_date] => 2016-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 24651 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560002 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560002
Gabaergic ligands and their uses Mar 17, 2016 Issued
Array ( [id] => 12239822 [patent_doc_number] => 20180072685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'METHOD FOR PRODUCING (4S)-4-[4-CYANO-2-(METHYLSULFONYL)PHENYL]-3,6-DIMETHYL-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-TETRAHYDRO PYRIMIDINE-5-CARBONITRILE' [patent_app_type] => utility [patent_app_number] => 15/559385 [patent_app_country] => US [patent_app_date] => 2016-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11750 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559385 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/559385
Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile Mar 14, 2016 Issued
Array ( [id] => 12233104 [patent_doc_number] => 20180065966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Antimicrobial Compounds And Methods Of Making And Using The Same' [patent_app_type] => utility [patent_app_number] => 15/557007 [patent_app_country] => US [patent_app_date] => 2016-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54205 [patent_no_of_claims] => 129 [patent_no_of_ind_claims] => 85 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557007 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/557007
Antimicrobial compounds and methods of making and using the same Mar 10, 2016 Issued
Menu